Cargando…
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection
Reverse hybrid therapy is an 1-step 2-phase treatment for Helicobacter pylori (H. pylori) infection with less cost than standard triple therapy. We conducted a randomized, controlled study to compare the efficacies of standard triple therapy and reverse hybrid therapy in the treatment of H. pylori i...
Autores principales: | Hsu, Ping-I, Kao, Sung-Shuo, Wu, Deng-Chyang, Chen, Wen-Chi, Peng, Nan-Jing, Yu, Hsien-Chung, Wang, Huay-Min, Lai, Kwok-Hung, Cheng, Jin-Shiung, Chen, Angela, Chuah, Seng-Kee, Tsay, Feng-Woei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674196/ https://www.ncbi.nlm.nih.gov/pubmed/26632893 http://dx.doi.org/10.1097/MD.0000000000002104 |
Ejemplares similares
-
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection
por: Wu, Deng-Chyang, et al.
Publicado: (2016) -
7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
por: Kao, Sung-Shuo, et al.
Publicado: (2012) -
Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014) -
Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy
por: Watanabe-Kusunoki, Kanako, et al.
Publicado: (2021) -
Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2020)